CopyMark Law Group
4.9/5
Drawing for JASCAYD

USPTO serial 79376569

JASCAYD

Reviewed by CopyMark Law Group

Reg. 7602170Status 700Registered
Filing date
Status date
Registration date
Dec 17, 2024
Examiner
BRECKENFELD, WILLIAM G
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with JASCAYD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Max Moskowitz

Max Moskowitz OSTROLENK FABER LLP845 THIRD AVENUE, 17th FloorBinger Str. 173New York, NY 10022

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 13, 2025FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
May 27, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 27, 2025FIMPFINAL DISPOSITION PROCESSED—
Mar 17, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 1, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 15, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 15, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 17, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 17, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 29, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 29, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 9, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 23, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 20, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 20, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 20, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 16, 2024RFNTREFUSAL PROCESSED BY IB—
Mar 22, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 22, 2024RFRRREFUSAL PROCESSED BY MPU—
Mar 2, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 1, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 29, 2024DOCKASSIGNED TO EXAMINER—
Aug 29, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 24, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 22, 2023LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Aug 17, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance